High-grade glial brain tumors are often characterized by an elevated expression of the tumorigenic epidermal growth factor receptor variant III ( EGFRvIII). researchers from the Apollo Hospitals Educational and Research Foundation sought to establish a clinically adaptive protocol as a noninvasive ...
Read More »Datar Genetics and AHERF announce collaboration to validate liquid biopsy for brain tumours
Collaboration study to validate and demonstrate clinical utility of Exosome-based diagnostics for providing individualised treatment decisions to Glioblastoma (GBM) patients Datar Genetics (Datar) has announced a strategic collaboration with Apollo Hospitals Educational and Research Foundation (AHERF). The collaboration envisages establishing ...
Read More »